Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans-Ulrich Häring

Showing results (1-10 of 504) with videos related to

Pageof 51
Sort By:
Diabetologia|June 27, 2016
Novel phenotypes of prediabetes?Hans-Ulrich Häring
Annals of Medicine|August 14, 2002
Glitazones: clinical effects and molecular mechanismsMichael Stumvoll, Hans-Ulrich Häring
Diabetes|July 27, 2011
The metabolically benign and malignant fatty liverNorbert Stefan, Hans-Ulrich Häring
Nature Reviews. Endocrinology|January 23, 2013
The role of hepatokines in metabolismNorbert Stefan, Hans-Ulrich Häring
Nature Medicine|April 6, 2013
Circulating fetuin-A and free fatty acids interact to predict insulin resistance in humansNorbert Stefan, Hans-Ulrich Häring
Endocrine Reviews|August 30, 2008
Causes and metabolic consequences of Fatty liverNorbert Stefan, Konstantinos Kantartzis, Hans-Ulrich Häring
Circulation|September 15, 2010
Letter by Stefan et al regarding article, "Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men"Norbert Stefan, Andreas Fritsche, Hans-Ulrich Häring
JAMA|March 6, 2008
Cardiorespiratory fitness, adiposity, and mortalityNorbert Stefan, Konstantinos Kantartzis, Hans-Ulrich Häring
JAMA|January 24, 2013
Measures of adiposity and fat distribution and risk of diabetesNorbert Stefan, Fritz Schick, Hans-Ulrich Häring
The New England Journal of Medicine|January 1, 2010
Sex hormone-binding globulin and risk of type 2 diabetesNorbert Stefan, Fritz Schick, Hans-Ulrich Häring
Pageof 51

Showing results (1-10 of 504) with videos related to

Sort By:
Pageof 51
Diabetologia|June 27, 2016
Novel phenotypes of prediabetes?Hans-Ulrich Häring
Annals of Medicine|August 14, 2002
Glitazones: clinical effects and molecular mechanismsMichael Stumvoll, Hans-Ulrich Häring
Diabetes|July 27, 2011
The metabolically benign and malignant fatty liverNorbert Stefan, Hans-Ulrich Häring
Nature Reviews. Endocrinology|January 23, 2013
The role of hepatokines in metabolismNorbert Stefan, Hans-Ulrich Häring
Nature Medicine|April 6, 2013
Circulating fetuin-A and free fatty acids interact to predict insulin resistance in humansNorbert Stefan, Hans-Ulrich Häring
Endocrine Reviews|August 30, 2008
Causes and metabolic consequences of Fatty liverNorbert Stefan, Konstantinos Kantartzis, Hans-Ulrich Häring
Circulation|September 15, 2010
Letter by Stefan et al regarding article, "Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men"Norbert Stefan, Andreas Fritsche, Hans-Ulrich Häring
JAMA|March 6, 2008
Cardiorespiratory fitness, adiposity, and mortalityNorbert Stefan, Konstantinos Kantartzis, Hans-Ulrich Häring
JAMA|January 24, 2013
Measures of adiposity and fat distribution and risk of diabetesNorbert Stefan, Fritz Schick, Hans-Ulrich Häring
The New England Journal of Medicine|January 1, 2010
Sex hormone-binding globulin and risk of type 2 diabetesNorbert Stefan, Fritz Schick, Hans-Ulrich Häring
Pageof 51